Physician profile
Brian S Raj
NPI 1508182981
$698.66
in general payments reported to CMS, 2019-2025
23 companies · $21.97 in 2025
The $21.97 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $35.45 · 2021: $82.06 · 2022: $145 · 2023: $198 · 2024: $21.19 · 2025: $21.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $82.15 | 2021-2023 | |
| Grifols USA, LLC | $60.77 | 2021-2022 | |
| Lundbeck LLC | $53.53 | 2022-2023 | Vyepti |
| Ucb, INC. | $46.49 | 2019-2020 | |
| Tanabe Pharma America, INC. | $39.71 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $37.71 | 2022-2023 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $36.80 | 2019-2024 | Ultomiris |
| Amylyx Pharmaceuticals, INC. | $29.32 | 2023 | Relyvrio |
| Mallinckrodt Enterprises LLC | $29.15 | 2019 | |
| Eisai INC. | $28.34 | 2019 | |
| Merz North America, INC. | $27.41 | 2019 | |
| Abbott Laboratories | $24.87 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $22.91 | 2022 | |
| Banner Life Sciences, LLC | $22.26 | 2023 | |
| Amgen INC. | $21.97 | 2025 | Uplizna |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $20.72 | 2023 | Nourianz |
| Neurocrine Biosciences, INC. | $20.59 | 2021 | |
| Greenwich Biosciences, INC. | $19.88 | 2019 | |
| Medtronic Vascular, INC. | $16.96 | 2019 | |
| Neurelis, INC. | $15.37 | 2021 | |
| Aquestive Therapeutics, INC. | $14.16 | 2020 | |
| Celgene Corporation | $13.92 | 2023 | Zeposia |
| Mdd US Operations, LLC | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Raj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.